Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193805-22-000971
Filing Date
2022-06-17
Accepted
2022-06-17 21:33:49
Documents
1
Period of Report
2022-06-15

Document Format Files

Seq Description Document Type Size
1 e621758_4-ossipow.html 4  
1 e621758_4-ossipow.xml 4 3820
  Complete submission text file 0001193805-22-000971.txt   5249
Mailing Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036
Business Address 1200 AVENUE OF THE AMERICAS SUITE 200 NEW YORK X1 10036 (332) 255-9818
IMMUNIC, INC. (Issuer) CIK: 0001280776 (see all company filings)

EIN.: 562358443 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CH. DES VIGNES 1 COMMUGNY V8 1291
Business Address
Ossipow Vincent (Reporting) CIK: 0001773679 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36201 | Film No.: 221025785